Novartis Oncology Talent Acquisition Specialist Salaries in Wilmington, DE
The average Novartis Oncology Talent Acquisition Specialist in Wilmington, DE earns an estimated $107,271 annually, which includes an estimated base salary of $92,833 with a $14,438 bonus. Novartis Oncology's Talent Acquisition Specialist compensation is $11,755 more than the US average for a Talent Acquisition Specialist. Talent Acquisition Specialist salaries at Novartis Oncology in Wilmington, DE can range from $25,000 - $205,000.
In Wilmington, DE, The HR Department at Novartis Oncology earns $14,442 more on average than the IT Department.
Last updated 3 years ago.
- $92,833
- avg. base
- $14,438
- avg. bonus
Talent Acquisition Specialist Salaries at Novartis Oncology
In Wilmington, DE, Talent Acquisition Specialists earn $4,795 more than Recruiters, and $14,794 less than HR Managers.
Compensation at Novartis Oncology by Department
In Wilmington, DE, The HR Department averages $14,442 more than the IT Department, and $6,404 less than the Design Department
Talent Acquisition Specialist Compensation by Gender (All Companies)
The average female Talent Acquisition Specialist at companies similar size to Novartis Oncology reported making $103,781, while the average male Talent Acquisition Specialist at similar sized companies reported making $118,755.
Talent Acquisition Specialist Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Talent Acquisition Specialist at companies similar size to Novartis Oncology reported making $122,536, while the average Hispanic or Latino Talent Acquisition Specialist at similar sized companies reported making $90,515.
How Talent Acquisition Specialists at Novartis Oncology Rate Their Compensation
The majority of Talent Acquisition Specialists at Novartis Oncology believe they're not compensated fairly. 100% of Talent Acquisition Specialists at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology
